This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Feb 23;28(8):1893-6.

doi: 10.1016/j.vaccine.2010.01.052.

Introduction to DNA vaccines - Las Vegas

David B Weiner, Niranjan Y Sardesai, Connie Schmaljohn

PMID: 20188243
DOI: 10.1016/j.vaccine.2010.01.052

Editorial

Introduction to DNA vaccines - Las Vegas

David B Weiner et al. Vaccine. 2010.

. 2010 Feb 23;28(8):1893-6.

doi: 10.1016/j.vaccine.2010.01.052.

Authors

David B Weiner, Niranjan Y Sardesai, Connie Schmaljohn

PMID: 20188243
DOI: 10.1016/j.vaccine.2010.01.052

No abstract available

PubMed Disclaimer

Similar articles

DNA vaccines and adjuvants.
Stevenson FK. Stevenson FK. Immunol Rev. 2004 Jun;199:5-8. doi: 10.1111/j.0105-2896.2004.00146.x. Immunol Rev. 2004. PMID: 15233722 No abstract available.
Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
Ramanathan MP, Kutzler MA, Kuo YC, Yan J, Liu H, Shah V, Bawa A, Selling B, Sardesai NY, Kim JJ, Weiner DB. Ramanathan MP, et al. Vaccine. 2009 Jul 9;27(32):4370-80. doi: 10.1016/j.vaccine.2009.01.137. Epub 2009 Mar 6. Vaccine. 2009. PMID: 19497647
Potentiation of an anthrax DNA vaccine with electroporation.
Luxembourg A, Hannaman D, Nolan E, Ellefsen B, Nakamura G, Chau L, Tellez O, Little S, Bernard R. Luxembourg A, et al. Vaccine. 2008 Sep 19;26(40):5216-22. doi: 10.1016/j.vaccine.2008.03.064. Epub 2008 Apr 16. Vaccine. 2008. PMID: 18462850
Use of CpG oligodeoxynucleotides as immune adjuvants.
Klinman DM, Currie D, Gursel I, Verthelyi D. Klinman DM, et al. Immunol Rev. 2004 Jun;199:201-16. doi: 10.1111/j.0105-2896.2004.00148.x. Immunol Rev. 2004. PMID: 15233736 Review.
DNA tumor vaccines.
Wlazlo AP, Ertl HC. Wlazlo AP, et al. Arch Immunol Ther Exp (Warsz). 2001;49(1):1-11. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11266084 Review.

See all similar articles

Cited by

Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
Jiang X, Dalebout TJ, Lukashevich IS, Bredenbeek PJ, Franco D. Jiang X, et al. J Gen Virol. 2015 Apr;96(Pt 4):804-814. doi: 10.1099/jgv.0.000026. Epub 2014 Dec 16. J Gen Virol. 2015. PMID: 25516543 Free PMC article.
Consensus HIV-1 FSU-A integrase gene variants electroporated into mice induce polyfunctional antigen-specific CD4+ and CD8+ T cells.
Krotova O, Starodubova E, Petkov S, Kostic L, Agapkina J, Hallengärd D, Viklund A, Latyshev O, Gelius E, Dillenbeck T, Karpov V, Gottikh M, Belyakov IM, Lukashov V, Isaguliants MG. Krotova O, et al. PLoS One. 2013 May 8;8(5):e62720. doi: 10.1371/journal.pone.0062720. Print 2013. PLoS One. 2013. PMID: 23667513 Free PMC article.
Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant.
Hartoonian C, Sepehrizadeh Z, Mahdavi M, Arashkia A, Jang YS, Ebtekar M, Yazdi MT, Negahdari B, Nikoo A, Azadmanesh K. Hartoonian C, et al. Mol Biol Rep. 2014 Sep;41(9):5943-52. doi: 10.1007/s11033-014-3470-5. Epub 2014 Jun 28. Mol Biol Rep. 2014. PMID: 24972567

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science